<li id="quy4e"></li>
<button id="quy4e"></button>
  • <button id="quy4e"><bdo id="quy4e"></bdo></button>
    <rt id="quy4e"></rt>
    <tfoot id="quy4e"></tfoot>
  • 咨詢熱線

    15000266580

    當前位置:首頁 >產品中心>細胞庫>人正常細胞>CCRF-SD人外周血淋巴細胞

    人外周血淋巴細胞

    簡要描述:CCL-120 CCRF-SD 人外周血淋巴細胞
    ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞|貼壁細胞|懸浮細胞|;細胞庫管理規范,
    提供的細胞株背景清楚,提供參考文獻和培養條件!

    • 產品型號:CCRF-SD
    • 廠商性質:生產廠家
    • 更新時間:2025-04-25
    • 訪  問  量:2298

    產品分類

    Product Category

    詳細介紹

    CCL-120 CCRF-SD 人外周血淋巴細胞

    ATCC® Number: CCL-120™ Price: $338.00

    Designations: CCRF-SB [CCRF SB]

    Depositors: GE Foley

    Biosafety Level: 2 [Cells Contain HERPESVIRUS ]

    Shipped

    : frozen

    Medium & Serum: See Propagation

    Growth Properties: suspension

    Organism: Homo sapiens (human


    Morphology: lymphoblast

    CCL-120 CCRF-SD 人外周血淋巴細胞

    Source: Organ: peripheral blood

    Disease: acute lymphoblastic leukemia

    Cell Type: B lymphoblast;

    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


    Antigen Expression: HLA A1, A2, B12, B17, Cw2

    DNA Profile (STR): Amelogenin: X,Y

    CSF1PO: 10,12

    D13S317: 10,12

    D16S539: 9,13

    D5S818: 11,12

    D7S820: 11,12

    THO1: 9,10

    TPOX: 8

    vWA: 18

    Isoenzymes: G6PD, B

    Age: 11.5 years

    Gender: male

    Ethnicity: Caucasian

    Comments: A T cell line (HSB-2, ATCC CCL-120.1) was also obtained from the same buffy coat preparation.

    Derived from a buffy coat preparation from a patient with ALL.

    The cells are EBNA positive.

    Propagation: ATCC complete growth medium: RPMI 1640 medium, 90%; fetal bovine serum, 10% - OR - Iscove's modified Dulbecco's medium, 90%; fetal bovine serum, 10%

    Temperature: 37.0°C

    Subculturing: Protocol: Cultures can be maintained by addition or replacement of medium. Establish new cultures at 3 X 10(5) viable cells/ml.

    Medium Renewal: Add fresh medium (10% to 20% by volume) every 2 to 3 days

    Related Products: derived from same individual:ATCC CCL-120.1

    References: 24413: . M.D. Anderson Hospital and Tumor Inst. Monograph. 21: ; 1967.

    25967: Adams RA. Formal discussion: the role of transplantation in the experimental investigation of human leukemia and lymphoma. Cancer Res. 27: 2479-2482, 1967. PubMed: 4170381



    CCL-120 CCRF-SD





















    產品咨詢

    留言框

    • 產品:

    • 您的單位:

    • 您的姓名:

    • 聯系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結果(填寫阿拉伯數字),如:三加四=7
    聯系方式

    郵箱:xiangfbio@163.com

    地址:上海市虹口區四平路710號7層

    咨詢熱線

    400-821-8510

    (周一至周日9:00- 19:00)

    在線咨詢
    • 掃一掃 微信咨詢

    Copyright©2025 上海復祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
    技術支持:化工儀器網    管理登陸
    主站蜘蛛池模板: 南江县| 平乡县| 普兰店市| 辽宁省| 龙海市| 枣阳市| 洮南市| 察隅县| 青冈县| 祁东县| 永登县| 宜兰市| 如东县| 东山县| 石渠县| 宾川县| 申扎县| 陆河县| 城口县| 遵义市| 马关县| 黔江区| 崇左市| 绩溪县| 托克托县| 巩留县| 遂溪县| 鸡西市| 宁强县| 连州市| 新河县| 北碚区| 巴彦县| 临夏市| 泉州市| 页游| 徐汇区| 陕西省| 灵石县| 卢氏县| 开阳县|